Vitrolife
247 SEK +10.17%2 investors are following this company
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
VITR
Daily low / high price
222.6 / 253.6
SEK
Market cap
33.46B SEK
Turnover
148.5M SEK
Volume
605K
Financial calendar
Interim report
24.10.2024
Annual report
30.01.2025
Interim report
16.04.2025
General meeting
29.04.2025
Interim report
16.07.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
William Demant Invest | 28.7 % | 28.7 % |
Bure Equity | 15.9 % | 15.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Vitrolife AB (publ): Interim report Q2, 2024: Strong Technologies growth and improved margins
Vitrolife AB (publ): Conference call interim report
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools